Z9R Stock Overview
A closed-ended fund launched and managed by The Family (Music) Limited. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Hipgnosis Songs Fund Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.17 |
| 52 Week High | €1.30 |
| 52 Week Low | €0.65 |
| Beta | 0.17 |
| 11 Month Change | 0% |
| 3 Month Change | -1.68% |
| 1 Year Change | 40.96% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 39.29% |
Recent News & Updates
Recent updates
Shareholder Returns
| Z9R | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.2% | 0.8% |
| 1Y | 41.0% | 26.2% | 8.6% |
Return vs Industry: Z9R exceeded the German Capital Markets industry which returned 37% over the past year.
Return vs Market: Z9R exceeded the German Market which returned 19.6% over the past year.
Price Volatility
| Z9R volatility | |
|---|---|
| Z9R Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: Z9R's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine Z9R's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 39 | Merck Mercuriadis | www.hipgnosissongs.com |
Hipgnosis Songs Fund Limited is a closed-ended fund launched and managed by The Family (Music) Limited. The fund invests in songs and associated musical intellectual property rights, including master recordings and producer royalties. Hipgnosis Songs Fund Limited was formed in 2018 and is domiciled in Guernsey.
Hipgnosis Songs Fund Limited Fundamentals Summary
| Z9R fundamental statistics | |
|---|---|
| Market cap | €1.23b |
| Earnings (TTM) | -€121.99m |
| Revenue (TTM) | €114.52m |
12.4x
P/S Ratio-11.6x
P/E RatioIs Z9R overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| Z9R income statement (TTM) | |
|---|---|
| Revenue | US$124.41m |
| Cost of Revenue | US$0 |
| Gross Profit | US$124.41m |
| Other Expenses | US$256.93m |
| Earnings | -US$132.52m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 100.00% |
| Net Profit Margin | -106.52% |
| Debt/Equity Ratio | 45.0% |
How did Z9R perform over the long term?
See historical performance and comparison